Simulations Plus, Inc. (SLP)
| Market Cap | 1.24B |
| Revenue (ttm) | 42.89M |
| Net Income (ttm) | 9.75M |
| Shares Out | 19.93M |
| EPS (ttm) | 0.51 |
| PE Ratio | 130.57 |
| Forward PE | 119.05 |
| Dividend | $0.24 |
| Dividend Yield | 0.36% |
| Trading Day | March 5 |
| Last Price | $66.46 |
| Previous Close | $62.25 |
| Change ($) | 4.21 |
| Change (%) | 6.76% |
| Day's Open | 62.97 |
| Day's Range | 61.57 - 67.00 |
| Day's Volume | 404,284 |
| 52-Week Range | 25.90 - 90.92 |
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant.
What's better than rapid growth and a dividend payment?
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the release of GastroPlus 9.8.1 with key enhancements to improve efficiency and inform regulatory decision making.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced an agreement to distribute Lixoft's MonolixSuite in China with Mosim, one of China's leading clinical CROs.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it is partnering with the Institute of Pharmaceutical Sciences (ICF) in Brazil, to expand into South America.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has awarded a grant to Uganda's Makerere University funding upgraded infrastructure to facilitate research.
Simulations Plus (SLP) fiscal first-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.
The company continues to anticipate swift, double-digit revenue growth over the next several quarters.
New York, New York--(Newsfile Corp. - January 12, 2021) - Levi & Korsinsky announces it has commenced an investigation of Simulations Plus, Inc. (NASDAQ: SLP) concerning possible breaches of ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that CEO Shawn O'Connor will present at the 23rd Annual Needham Virtual Growth Conference on January 14, 2021, at 2pm ET.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration with a large pharmaceutical partner to enhance PBPK/PD models for pulmonary therapeutics.
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q1 2021 Results - Earnings Call Transcript
Simulations Plus (SLP) delivered earnings and revenue surprises of 9.09% and 1.35%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Simulations Plus (NASDAQ:SLP) were flat after the company reported Q1 results. Quarterly Results Earnings per share increased 9.09% year over year to $0.12, which beat the estimate o...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported record 1st quarter results for FY2021. Net revenues of $10.7 million increased 14%; net income was up 21% over 1QFY20.
Simulations Plus (NASDAQ:SLP) releases its next round of earnings this Monday, January 11. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
Simulations Plus (SLP) fiscal first-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech i...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration to enhance its GastroPlus ACAT model with novel mechanisms for oral peptide formulations.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report its first quarter fiscal year 2021 results on Monday, Jan. 11, 2021, with a webcast at 4:15 pm ET
We discuss three software stocks -- COUP, NUAN and SLP -- which might not sustain market beating run in 2021, owing to persistent macroeconomic weakness across SMBs induced by coronavirus outb...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has published its inaugural Environmental, Social and Governance (ESG) report on its website's Investors page
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the appointment of Will Frederick as CFO, succeeding John Kneisel who is retiring after 7 years with the Company.
Simulations Plus (SLP) fiscal fourth-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.
Simulations Plus' (SLP) CEO Shawn O'Connor on Q4 2020 Results - Earnings Call Transcript
Simulations Plus (SLP) delivered earnings and revenue surprises of 20.00% and 0.85%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Simulations Plus (NASDAQ:SLP) fell 2.16% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year t...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported results for the 4th quarter and fiscal year 2020. Full FY20 revenues increased 22.4%; 4QFY20 revenues increased 18.9%.
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report its 4th quarter and fiscal year 2020 results on Mon., Nov. 16, 2020, with a webcast at 4:15 pm ET
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that CEO Shawn O'Connor will be participating in the Credit Suisse Virtual Healthcare Conference on Nov. 10, 2020.
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the release of GastroPlus 9.8 with key improvements to non-oral delivery models, virtual bioequivalence, and DDIs.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that its Board of Directors has declared a cash dividend of $0.06 per share to be distributed on Nov. 2, 2020.
There’s a difference between high-priced and expensive, and some of the best growth stocks to buy under $1,000 come with big price tags. The post The 7 Best Growth Stocks To Buy For Less Than$...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced it has entered a second phase of its collaboration to enhance & expand HTPK Simulation technology in ADMET Predictor.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has partnered with a large pharmaceutical company to validate the AIDD Module in ADMET Predictor 10.0 (APX).
LANCASTER, Calif--(BUSINESS WIRE)--Simulations Plus today announced the release of ADMET Predictor 10.0 (APX) - a major upgrade with new AI-Driven Drug Design & Transporters Modules.
Three great performing yet relatively unknown med-tech stocks with a high upside.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that chief executive officer Shawn O'Connor will present at LD Micro's LD 500 Virtual Conference on Sept.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the closing of its public offering and the full exercise of the underwriters’ option to purchase additional shares.
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the entry into an underwriting agreement for the sale of 1,818,182 shares of its common stock priced at $55 per share
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering.
Simulation Plus: One-Of-A-Kind Bioinformatics Co. With A 20% 3-Year CAGR
Simulations Plus (SLP) third-quarter fiscal 2020 results reflect solid software and service revenue growth amid coronavirus crisis.
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q3 2020 Results - Earnings Call Transcript
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of these businesses are making big moves in response to upcoming index changes. Here are the must-know details.
The Oracle of Omaha can't touch these high-growth businesses, but you can.
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q2 2020 Results - Earnings Call Transcript
About SLP
Simulations Plus develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus... [Read more...]
| Industry Health Information Services | IPO Date Jun 18, 1997 |
| Stock Exchange NASDAQ | Ticker Symbol SLP |
Financial Performance
In 2020, SLP's revenue was $41.59 million, an increase of 22.43% compared to the previous year's $33.97 million. Earnings were $9.33 million, an increase of 8.72%.
Analyst Forecasts
According to 4 analysts, the average rating for SLP stock is "Buy." The 12-month stock price forecast is 87.00, which is an increase of 30.91% from the latest price.